InvestorsHub Logo

doogdilinger

10/06/17 7:11 AM

#30334 RE: fabius #30332

Wow very nice thnx fabius

wimuskyfisherman

10/06/17 10:35 AM

#30342 RE: fabius #30332

Fabius- Based on that number I would say IPCI gets about 10%(or possibly a little more) of the profits for Focalin. Do you agree with that or have another estimate?

doogdilinger

10/06/17 11:07 AM

#30349 RE: fabius #30332

Huge knowing that PAR's FocalinXR sales aren't dropping off after the 180 day exclusivity period on the 4 additional strengths ended on June 30th fabius!

AngeloFoca

10/06/17 5:55 PM

#30373 RE: fabius #30332

Seroquel + Focalin Sales to 9/29/17



Note that FACTUAL Sept 2017 year to date Sales of $57.25 million was used to derive assumed Jan and Feb sales #s.

2nd quarter Sales for Focalin were $20.41 million - from that and 2nd Qtr royalty payments we can get a very good estimation of Royalty %age for Focalin... and can get a very good estimate on Focalin's 3rd Qtr royalty payments... now who has the exact 2nd qtr payment on Focalin??? If it was $2 million??? then 10% royalty on 3rd Qtr Focalin Royalties will be $1.763 million.

Looking forward to figuring out Seroquel's Royalties next Earnings Report.







AngeloFoca

10/07/17 7:22 PM

#30376 RE: fabius #30332

TOTAL TRX dollars
August was 6.69Mln

Sept weekly data (as of 29th Sept) already sum up to 7.77Mln

Ytd total sales are at 57.25mln

Angelo, other numbers for your spreadsheets

Fabius... the Jan & Feb 2017 Focalin Sales are "Estimates" which I derived from March to Sept actual #s and the Yearly total so far of $57.25 million.

However... those 2 months actual #s exist... and if you can dig them up, I'll plug the actual #s in the SS... I'll feel more comfortable that way.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=135212265